Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of three concentrations of rEV131, a new investigational anti-inflammatory agent, compared to placebo (an inactive substance) and an FDA approved anti-inflammatory agent in patients with ocular inflammation who have undergone cataract extraction with intra-ocular lens implantation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind


Related Conditions & MeSH terms


NCT number NCT00353964
Study type Interventional
Source Evolutec Group
Contact Susan French, ORA Clinical Research & Development Inc.
Phone 978-685-8900
Email sfrench@oraclinical.com
Status Recruiting
Phase Phase 2

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Not yet recruiting NCT05248139 - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery N/A
Terminated NCT01214174 - Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients Phase 2
Completed NCT03332342 - Closed Eye Neutrophils in Dry Eye Disease N/A
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT01808547 - Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects Phase 3
Completed NCT04374656 - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Recruiting NCT05668455 - Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses) Phase 3
Completed NCT00645671 - Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery Phase 3
Completed NCT00789971 - Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification N/A
Completed NCT02786901 - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Phase 3
Completed NCT00699153 - Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery Phase 3
Terminated NCT03596723 - KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children Phase 3
Completed NCT01576952 - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects Phase 3
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03580473 - Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification Phase 2
Completed NCT04812951 - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery Early Phase 1
Completed NCT03302273 - Corneal Epithelial Stem Cells and Dry Eye Disease N/A
Completed NCT04690829 - Biomarkers in Ocular Inflammation and Uveitis
Withdrawn NCT01721694 - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Phase 3